mortality/aging
• most mice hemizygous for the transgene die between the ages of 2 and 6 months
|
immune system
• transgene hemizygotes develop severe lymphadenopathy, but only minimal splenomegaly
|
neoplasm
• hemizygous transgenics develop clonal B-lineage lymphomas; their spleens and lymph nodes contain "uniform populations of IgM+CD19+CD5-CD23- cells"
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Burkitt lymphoma | DOID:8584 |
OMIM:113970 |
J:65245 |